Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
This move, awaiting formal approval by the European Commission, is a substantial blow to GSK's oncology business, especially considering Blenrep's prominence as the second-largest contributor to this segment in 2022.